CClinicalTrials.gg
CompletedNCT06241040Updated Apr 19, 2024

Effects of Aerobic Exercise and Core Muscle Strengthening on Pain, Menstrual Pattern and QOL in Endometriosis

An interventional study of Aerobic Exercises with core Muscle strengthening and Aerobic Exercise without Core Muscle Strengthening in Endometriosis, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to female participants aged 18 Years to 49 Years. Per ClinicalTrials.gov, last updated 2024-04-19.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Mar 2023, registered Jan 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
Female
01

Study summary

Endometriosis is a complex and debilitating gynecological condition affecting millions of women worldwide. It is characterized by the abnormal growth of endometrial-like tissue outside the uterus, leading to chronic pelvic pain, dysmenorrhea, dyspareunia, and reduced quality of life. While pharmacological interventions are commonly prescribed to manage symptoms, their efficacy may be limited, and they often come with adverse effects. Therefore, exploring non-pharmacological approaches, such as exercise, is crucial in improving the management of endometriosis-related symptoms. Aerobic exercise has gained attention as a potential therapeutic intervention for endometriosis due to its positive effects on pain modulation, hormonal regulation, and overall well-being.

Read the detailed description

This randomized controlled trial (RCT) will be conducted at Jinnah Hospital in Lahore, Pakistan, to investigate the effects of aerobic exercise with and without core muscle strengthening on pain, menstrual pattern, and quality of life in women diagnosed with endometriosis. The study will employ a convenient randomization sampling technique, aiming to recruit approximately 30 participants who meet the inclusion criteria. Eligible participants will be reproductive-age women experiencing endometriosis-related pain, with regular menstrual cycles or irregularities associated with endometriosis. They should be medically stable, cleared for physical activity, and willing to participate in an exercise intervention program. Exclusion criteria include pregnancy, severe endometriosis-related complications, significant comorbidities, recent surgery, ongoing hormonal treatments targeting endometriosis, inability to participate in exercise programs, and severe mental health conditions. By investigating these interventions, the study seeks to improve symptom management, menstrual regularity, and overall quality of life for women with endometriosis while considering safety and feasibility within the study setting.

Keywords: Endometriosis, Menstrual pattern, Aerobic Exercise, Core Muscle Strengthening, Quality of Life

02

Conditions studied

  • Endometriosis

Keywords

  • Endometriosis
  • Menstrual pattern
  • Aerobic Exercise
  • Core Muscle Strengthening
  • Quality of Life
03

In context

Endometriosis

901 studies on the registry are indexed under Endometriosis; 259 are open to participants now.

This study's enrollment of 30 is below the median of 64 across 525 interventional studies indexed under Endometriosis.

Browse Endometriosis studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women diagnosed with endometriosis.(16)
  • Age range (e.g., 18-49 years)
  • Regular menstrual cycles or menstrual irregularities associated with endometriosis.
  • Medically stable and cleared for participation in physical activity.
  • No contraindications for aerobic exercise or core muscle strengthening

Exclusion criteria

Exclusion Criteria:

  • Pregnant individuals or those actively trying to conceive.
  • Recent endometriosis-related surgeries/procedures
  • Use of hormonal therapies/medications targeting endometriosis
  • Severe endometriosis complications requiring immediate medical intervention
  • Inability to engage in aerobic exercise.
  • Significant cardiovascular/respiratory conditions
  • Concurrent participation in another exercise/rehabilitation program
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Aerobic Exercise Group with Core Muscle strengthening Group

    Participants assigned to this group will undergo a combination of aerobic exercise and core muscle strengthening interventions. The aerobic exercise component will be similar to the first group, while additional exercises targeting the core muscles (abdomen, back, and pelvis) will be included.

    Other: Aerobic Exercises with core Muscle strengthening

  • Active comparator
    Aerobic Exercise without Core Muscle Strengthening Group

    Participants assigned to this group will engage in aerobic exercise interventions

    Other: Aerobic Exercise without Core Muscle Strengthening

Interventions

  • OtherAerobic Exercises with core Muscle strengthening

    Participants assigned to this group will undergo a combination of aerobic exercise and core muscle strengthening interventions. The aerobic exercise component will be similar to the first group, while additional exercises targeting the core muscles (abdomen, back, and pelvis) will be included.

  • OtherAerobic Exercise without Core Muscle Strengthening

    Aerobic Exercise without Core Muscle Strengthening

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale for Pain:

    The Visual Analog Scale (VAS) for Pain is a commonly used instrument for assessing pain intensity. It is a subjective measure that asks individuals to rate their pain on a continuous line or scale. The VAS typically consists of a 10 cm line with anchor points representing "no pain" on one end and "worst possible pain" on the other end. Participants are instructed to mark the line at the point that represents their current level of pain.

    Time frame: 8 weeks

  2. Endometrial Health Profile-30 Endometrial Health Profile

    The EHP-30 (Endometrial Health Profile-30) is a specific questionnaire designed to assess the impact of endometriosis on various aspects of a person's life. It is a self-report instrument that measures health-related quality of life in individuals with endometriosis.

    Time frame: 8 weeks

  3. Menstrual pattern Bleeding score MIQ questionnaire

    The Menstrual Pattern Bleeding Score MIQ (Menstrual Impact Questionnaire) questionnaire is a specific tool used to assess the impact of menstrual patterns and bleeding on individuals' lives. It is a self-report questionnaire that measures the severity and impact of menstrual symptoms and irregularities on various aspects of daily functioning.

    Time frame: 8 weeks

07

Study locations

1 site
  • Jinnah Hospital
    Lahore, Punjab 44000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06241040
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Feb 5, 2024
Start date
Mar 15, 2023
Primary completion
Mar 15, 2024
Completion
Mar 15, 2024
Last update
Apr 19, 2024

Study contacts

Faiza Taufiq, PPDPT
principal investigator · Riphah International University, Senior Lecturer

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion